(Q46099469)

English

Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population

scientific article published in January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

Nicholas Talley

5

object named as

Nicholas J Talley

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

author name string

Lars Agréus

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

Tom Storskrubb

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

Pertti Aro

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

Jukka Ronkainen

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

Pentti Sipponen

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

Scandinavian Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

44

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

564-570

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

The pivotal role of John S. Edkins in the discovery of gastrin

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Topical review. Gastrin and gastric epithelial physiology

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Growth-promoting effects of glycine-extended progastrin

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Glycine-extended gastrin-17 stimulates acid secretion only via CCK-2 receptor-induced histamine release in the totally isolated vascularly perfused rat stomach

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Hypergastrinemia in animals and man: causes and consequences.

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Serum Group I Pepsinogens During Prolonged Infusion of Pentagastrin and Secretin in Man

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man.

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status.

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Rebound hypersecretion after inhibition of gastric acid secretion

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study.

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Inflammatory bowel disease, past, present and future: lessons from animal models

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Marked increase in gastric acid secretory capacity after omeprazole treatment

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole.

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group

1 reference

https://api.crossref.org/works/10.1080%2F00365520902745062

21 January 2018

Identifiers

10.1080/00365520902745062

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19263272

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46099469&oldid=2092469387"